O.N. SIGITOVA^1,2, A.S. KHAYRULLOV², A.R. BOGDANOVA¹, E.V. ARKHIPOV¹

¹Kazan State Medical University, 49 Butlerov St., Kazan, Russian Federation, 420012

²Republican Clinical Hospital of the MH of RT, 138 Orenburgskiy Trakt, Kazan, Russian Federation, 420064

Sigitova O.N, D. Med. Sc., Professor, Head of the Department of General Practice, tel. +7-917-396-24-17, e-mail: [email protected]

Khayrullov A.S, Cand. Med. Sc., deputy chief physician of polyclinic section work, tel. (843) 231-20-45, е-mail: [email protected]

Bogdanova A.R, Cand. Med. Sc., Assistant of the Department of General Practice, tel. +7-927-246-63-94, e-mail: [email protected]

Arkhipov E.V, Cand. Med. Sc., Assistant of the Department of General Practice, tel. +7-903-342-53-25, e-mail: [email protected]

Ischemic renal long time has no specific symptoms, and therefore usually detected at late stages of chronic kidney disease. Early diagnosis and prompt treatment can not only reduce the incidence of end-stage renal failure and reduce the risk of cardiovascular complications, but also to change patients’ life expectancy.

Key words: ischemic kidney disease, diagnostics, treatment, antihypertensive therapy, evidence-based medicine.

REFERENCES

1. Shilov E.M., Shvetsov M.Yu., Bobkova I.N. et al. Khronicheskaya bolezn’ pochek i nefroprotektivnaya terapiya. Metodicheskoe rukovodstvo dlya vrachey [Chronic kidney disease and renal protection treatment. Methodological guide for physicians]. Moscow, 2012. 76 p.
2. Kalra P.A., Guo N., Kausz A.T. et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int, 2005, vol. 68(1), rr. 293-301.
3. Ruggenenti P.A. Schieppati, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet, 2001, vol. 357, rr. 1601-1608.
4. Sidorenko B.A., Preobrazhenskiy D.V., Batyraliev T.A. Ingibitory angiotenzin-prevrashchayushchego fermenta. Izdanie vtoroe, ispravlennoe, dopolnennoe: Monografiya [Batyraliev Angiotensin-converting enzyme. Second edition, revised, enlarged: Monograph]. Moscow: Litterra, 2007. 352 p.
5. Alkazar J.M., Rodicio J.L. Ischemic nephropathy: clinical characteristics and treatment. Am.J.Kidney. Dis, 2000, vol. 36, no. 5, pp. 883-893.
6. Fomin V.V., Moiseev S.V., Shvetsov M.Yu. Hypertension in ischemic renal disease: clinical features and course. Terapevticheskiy arkhiv, 2005, no. 6, pp. 27-32 (in Russ.).
7. Igonin V.A. Arterial’naya gipertoniya pri ishemicheskoy bolezni pochek: klinicheskie proyavleniya, osobennosti diagnostiki, sostoyanie pressornykh mekhanizmov i endotelial’noy funktsii, puti optimizatsii lecheniya: avtoref. dis. … d-ra med. nauk [Hypertension in ischemic renal disease: clinical presentation, diagnostic features, state of the pressor mechanisms and endothelial function, ways to optimize treatment. Synopsis of dis. Dr med. sci]. Moscow, 2007. 47 p.
8. Bogdanova A.R. Kliniko-funktsional’nye, gemodinamicheskie i strukturno-kletochnye aspekty patogeneza khronicheskoy bolezni pochek u patsientov s ishemicheskoy bolezn’yu serdtsa: avtoref. dis. … kand. med. nauk [Clinical and functional hemodynamic and structural and cellular aspects of the pathogenesis of chronic kidney disease in patients with coronary heart disease. Synopsis of dis. PhD med. sci]. Izhevsk, 2014. 133 p.
9. Sigitova O.N., Bogdanova A.R., Arkhipov E.V. About the risk factors, especially current and criteria for diagnosis of ischemic renal disease in patients with ischemic heart disease. Arkhiv vnutrenney meditsiny, 2013, no. 5 (13), pp. 16-20 (in Russ.).
10. Baboola K., Evans S., Moore R.H. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. American Journal of Kidney Disease, 1998, vol. 31, pp. 971-977.
11. Fomin V.V., Taronishvili O.I., Shvetsov M.Yu. Increasing azotemia, provoked by appointment of an angiotensin-converting enzyme in ischemic renal disease. Terapevticheskiy arkhiv, 2004, no. 9, pp. 66-70 (in Russ.).
12. Mukhin N.A., Kozlovskaya L.V., Shilov E.M., Gordovskaya G.B. Ratsional’naya farmakoterapiya v nefrologii: Ruk. dlya prak. vrachey [Rational pharmacotherapy in nephrology: Hands. for prac. doctors]. Moscow: Literra, 2006. 896 p.
13. Funktsional’noe sostoyanie pochek i prognozirovanie serdechno-sosudistogo riska [Renal function and prediction of cardiovascular risk]. Rekomendatsii Komiteta ekspertov Vserossiyskogo nauchnogo obshchestva kardiologov i Nauchnogo obshchestva nefrologov Rossii. Moscow, 2009. 45 p.
14. Johansson M., Herlitz H., Jensen G. et al. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation toisympathetic activation, renal function and treatment regimens. J. Hypertens, 1999, vol. 17, rr. 1743-1750.
15. Hirsch A.T., Haskal Z.J., Hertzer N.R. et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease) summary of recommendations. J. Vasc. Interv. Radiol, 2006, vol. 17, pp. 1383-1397.
16. Balzer K.M., Pfeiffer T., Rossbach S. et al. Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD). J. Vasc. Surg, 2009, vol. 49, pp. 667-674.
17. Kutyrina I.M., Shvetsov M.Yu., Fomin V.V., Tsygin A.N., Shestakova M.V., Shutov A.M. Klinicheskie rekomendatsii po diagnostike i lecheniyu pochechnoy arterial’noy gipertenzii [Clinical guidelines for diagnosis and treatment of renal hypertension]. Moscow, 2014. 50 p.
18. Rekomendatsii Evropeyskogo obshchestva kardiologov i Evropeyskogo obshchestva ateroskleroza po lecheniyu dislipidemiy [Recommendations of the European Society of Cardiology and the European Society for the treatment of dyslipidemias, atherosclerosis]. Ratsional’naya farmakoterapiya v kardiologii, 2012. 62 p.
19. Rekomendatsii evropeyskogo obshchestva kardiologov po diagnostike i lecheniyu zabolevaniy perifericheskikh arteriy. Rabochaya gruppa po diagnostike i lecheniyu zabolevaniy perifericheskikh arteriy Evropeyskogo obshchestva kardiologov [Recommendations of the European Society of Cardiology for the diagnosis and treatment of peripheral arterial disease]. Ratsional’naya farmakoterapiya v kardiologii, 2012, suppl. 4. 73 p.